Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-25-065619
Filing Date
2025-05-07
Accepted
2025-05-07 16:05:27
Documents
56
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q mrus-20250331.htm   iXBRL 10-Q 2755680
2 EX-10.1 mrus-ex10_1.htm EX-10.1 606115
3 EX-31.1 mrus-ex31_1.htm EX-31.1 17739
4 EX-31.2 mrus-ex31_2.htm EX-31.2 17379
5 EX-32.1 mrus-ex32_1.htm EX-32.1 15201
  Complete submission text file 0000950170-25-065619.txt   11662676

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT mrus-20250331.xsd EX-101.SCH 951550
59 EXTRACTED XBRL INSTANCE DOCUMENT mrus-20250331_htm.xml XML 2723658
Mailing Address YALELAAN 62 3584 CM UTRECHT DE
Business Address YALELAAN 62 3584 CM UTRECHT DE 31 030 253 8800
Merus N.V. (Filer) CIK: 0001651311 (see all company filings)

EIN.: 000000000 | State of Incorp.: P7 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37773 | Film No.: 25921230
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)